AMMONIUM LACTATE

AMMONIUM LACTATE was reported 2181 times

AMMONIUM LACTATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HETEROGENEOUSLY DENSE BREASTS 2 0.2500
1 SKIN HYPERPLASIA 3 0.0526
2 BLOOD HYPOSMOSIS 2 0.0500
3 MAGNESIUM METABOLISM DISORDER 2 0.0408
4 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 3 0.0357
5 KERATOSIS FOLLICULAR 2 0.0256
6 FACIAL OPERATION 4 0.0248
7 INTRACARDIAC PRESSURE INCREASED 2 0.0227
8 NEUROFIBROMA 2 0.0133
9 BONE METABOLISM DISORDER 4 0.0133
10 NAEVUS FLAMMEUS 2 0.0128
11 CEREBRAL AMYLOID ANGIOPATHY 4 0.0121
12 KERATOSIS PILARIS 3 0.0120
13 BORDERLINE GLAUCOMA 2 0.0108
14 HEPATITIS B ANTIBODY POSITIVE 2 0.0106
15 SKIN ULCER HAEMORRHAGE 4 0.0104
16 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
17 DEAFNESS PERMANENT 2 0.0102
18 HEPATITIS A ANTIBODY POSITIVE 2 0.0101
19 CARDIAC FAILURE HIGH OUTPUT 2 0.0083
20 HYPERPARATHYROIDISM SECONDARY 18 0.0072
21 CHONDROMALACIA 2 0.0070
22 LENTIGO 3 0.0060
23 CHRONIC RESPIRATORY DISEASE 2 0.0057
24 NEPHROGENIC ANAEMIA 24 0.0052
25 CHRONIC HEPATITIS C 2 0.0051
26 BONE DEMINERALISATION 5 0.0047
27 MITRAL VALVE CALCIFICATION 3 0.0047
28 HAEMANGIOMA OF SKIN 2 0.0046
29 STASIS DERMATITIS 3 0.0044
30 NECROTISING OESOPHAGITIS 2 0.0040
31 CAPILLARY FRAGILITY 2 0.0039
32 CORONAVIRUS TEST POSITIVE 4 0.0039
33 ESSENTIAL HYPERTENSION 7 0.0038
34 GALLBLADDER ENLARGEMENT 4 0.0037
35 GENITAL DISCOMFORT 2 0.0036
36 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 2 0.0036
37 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
38 ELECTRIC SHOCK 3 0.0035
39 NEURODERMATITIS 12 0.0032
40 FRACTURED SACRUM 4 0.0032
41 END STAGE RENAL DISEASE 55 0.0030
42 BLOOD FOLATE DECREASED 2 0.0028
43 RENAL TUBULAR ACIDOSIS 6 0.0027
44 ECONOMIC PROBLEM 37 0.0024
45 ARTHROPOD STING 4 0.0024
46 COVID-19 IMMUNISATION 2 0.0024
47 CUTANEOUS T-CELL LYMPHOMA 3 0.0024
48 HYPERKERATOSIS 13 0.0024
49 HIRSUTISM 3 0.0023
50 ANAEMIA OF CHRONIC DISEASE 2 0.0022
51 CERUMEN IMPACTION 2 0.0022
52 HAEMOCHROMATOSIS 2 0.0022
53 NAIL INFECTION 3 0.0021
54 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
55 ANHEDONIA 52 0.0020
56 APPLICATION SITE DISCOLOURATION 8 0.0020
57 BRAIN DEATH 6 0.0019
58 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
59 SCLERODERMA 7 0.0019
60 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
61 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
62 BURNS THIRD DEGREE 2 0.0019
63 SKIN DISCOMFORT 5 0.0019
64 COLONIC POLYP 3 0.0018
65 TONSILLAR HYPERTROPHY 3 0.0018
66 SKIN HYPERTROPHY 5 0.0018
67 METABOLIC SURGERY 2 0.0018
68 GROIN ABSCESS 2 0.0017
69 CHRONIC KIDNEY DISEASE 127 0.0017
70 CHRONIC RESPIRATORY FAILURE 2 0.0017
71 REBOUND ACID HYPERSECRETION 5 0.0017
72 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
73 POST-ACUTE COVID-19 SYNDROME 2 0.0016
74 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
75 PRE-EXISTING CONDITION IMPROVED 10 0.0016
76 ANION GAP INCREASED 2 0.0015
77 BODY MASS INDEX INCREASED 2 0.0015
78 EYELID PAIN 3 0.0015
79 INFUSION SITE RASH 2 0.0015
80 DISCHARGE 2 0.0014
81 ELECTRIC SHOCK SENSATION 4 0.0014
82 ATRIAL TACHYCARDIA 3 0.0014
83 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
84 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23 0.0014
85 CHRONIC SINUSITIS 5 0.0013
86 DIABETIC FOOT 4 0.0013
87 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0013
88 LYMPHOEDEMA 9 0.0013
89 REHABILITATION THERAPY 5 0.0013
90 GASTRITIS EROSIVE 6 0.0013
91 INGROWING NAIL 3 0.0013
92 NASAL ULCER 2 0.0013
93 COSTOCHONDRITIS 2 0.0012
94 HAEMATOLOGICAL INFECTION 3 0.0012
95 PERIPHERAL VENOUS DISEASE 5 0.0012
96 RENAL TUBULAR NECROSIS 12 0.0012
97 DERMAL CYST 3 0.0012
98 METASTASES TO PERITONEUM 3 0.0012
99 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
100 BILIARY DYSKINESIA 2 0.0012
101 BLADDER NEOPLASM 2 0.0012
102 ABNORMAL UTERINE BLEEDING 3 0.0012
103 PERIPHERAL VASCULAR DISORDER 6 0.0012
104 MILIARIA 2 0.0012
105 HAEMORRHAGIC STROKE 9 0.0012
106 AORTIC STENOSIS 4 0.0011
107 ALOPECIA AREATA 2 0.0011
108 DECREASED ACTIVITY 12 0.0011
109 OESOPHAGEAL SPASM 2 0.0011
110 EYE OPERATION 5 0.0011
111 NEPHROPATHY 10 0.0011
112 HYPERTENSIVE HEART DISEASE 2 0.0011
113 TIBIA FRACTURE 5 0.0011
114 HYPERTONIC BLADDER 3 0.0010
115 ENTEROCOCCAL INFECTION 5 0.0010
116 OCULAR HYPERTENSION 2 0.0010
117 FAECES HARD 4 0.0010
118 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
119 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
120 POLYDIPSIA 4 0.0010
121 CEREBRAL ATROPHY 4 0.0010
122 SKIN PAPILLOMA 4 0.0010
123 DEVICE RELATED SEPSIS 2 0.0010
124 OSTEOPENIA 15 0.0010
125 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
126 GOITRE 4 0.0010
127 IMPAIRED QUALITY OF LIFE 14 0.0010
128 ANAL PRURITUS 2 0.0010
129 PHYSICAL ASSAULT 2 0.0010
130 BREAST CANCER RECURRENT 3 0.0009
131 DEVICE CONNECTION ISSUE 2 0.0009
132 ACUTE RESPIRATORY FAILURE 18 0.0009
133 OVERWEIGHT 5 0.0009
134 LYMPHOCYTE COUNT INCREASED 3 0.0009
135 DIVERTICULUM INTESTINAL 4 0.0009
136 NEAR DEATH EXPERIENCE 3 0.0009
137 DIABETIC NEPHROPATHY 2 0.0009
138 PLANTAR FASCIITIS 3 0.0009
139 APPLICATION SITE URTICARIA 2 0.0009
140 ANAL INCONTINENCE 8 0.0009
141 IRON DEFICIENCY 4 0.0009
142 DIABETIC RETINOPATHY 3 0.0009
143 VASCULAR DEVICE INFECTION 4 0.0009
144 EYE DISCHARGE 9 0.0009
145 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
146 LICHEN PLANUS 2 0.0009
147 CAROTID ARTERY STENOSIS 3 0.0009
148 DERMATITIS ATOPIC 45 0.0009
149 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
150 SARCOIDOSIS 4 0.0008
151 HYPERLIPIDAEMIA 10 0.0008
152 LACUNAR INFARCTION 2 0.0008
153 RENAL TRANSPLANT 3 0.0008
154 MONOCYTE COUNT INCREASED 3 0.0008
155 INGUINAL HERNIA 5 0.0008
156 SKIN FISSURES 16 0.0008
157 BONE DENSITY DECREASED 25 0.0008
158 SNORING 3 0.0008
159 ANGLE CLOSURE GLAUCOMA 2 0.0008
160 THYROID MASS 3 0.0008
161 BLOOD CHLORIDE DECREASED 2 0.0008
162 EPIGASTRIC DISCOMFORT 3 0.0008
163 NAIL DISCOLOURATION 3 0.0008
164 PRODUCT PREPARATION ISSUE 5 0.0008
165 RENAL FAILURE 100 0.0008
166 HYPERPHAGIA 3 0.0008
167 AZOTAEMIA 3 0.0008
168 BLEPHARITIS 3 0.0007
169 VITAMIN B12 DEFICIENCY 3 0.0007
170 GAMBLING DISORDER 2 0.0007
171 CHONDROPATHY 2 0.0007
172 MIGRAINE WITH AURA 2 0.0007
173 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
174 CLUMSINESS 2 0.0007
175 APPLICATION SITE EXFOLIATION 3 0.0007
176 MACULE 2 0.0007
177 VITAMIN D DEFICIENCY 7 0.0007
178 SKIN INFECTION 8 0.0007
179 OSTEOPOROSIS 29 0.0007
180 INTERVERTEBRAL DISC DISORDER 3 0.0007
181 GRANULOCYTOPENIA 4 0.0007
182 IRRITABLE BOWEL SYNDROME 15 0.0007
183 PHARYNGEAL DISORDER 2 0.0007
184 FIBULA FRACTURE 2 0.0007
185 SCIATICA 11 0.0007
186 SKIN WARM 4 0.0007
187 FOOT FRACTURE 13 0.0007
188 DEVICE POWER SOURCE ISSUE 2 0.0007
189 RHINITIS ALLERGIC 3 0.0007
190 CARDIAC PACEMAKER INSERTION 4 0.0007
191 INFUSION SITE REACTION 2 0.0007
192 GOUT 12 0.0007
193 WRIST FRACTURE 8 0.0007
194 METABOLIC ENCEPHALOPATHY 2 0.0007
195 SCRATCH 7 0.0007
196 HIV INFECTION 2 0.0007
197 HEREDITARY ANGIOEDEMA 7 0.0007
198 IRON DEFICIENCY ANAEMIA 6 0.0006
199 PIGMENTATION DISORDER 4 0.0006
200 ROSACEA 3 0.0006
201 FEELING OF DESPAIR 3 0.0006
202 NASAL DRYNESS 4 0.0006
203 VAGINAL INFECTION 3 0.0006
204 INFUSION SITE SWELLING 4 0.0006
205 FOREIGN BODY IN THROAT 2 0.0006
206 VULVOVAGINAL PAIN 3 0.0006
207 PORTAL VEIN THROMBOSIS 2 0.0006
208 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
209 ANEURYSM 3 0.0006
210 APPLICATION SITE SWELLING 3 0.0006
211 SKIN MASS 4 0.0006
212 BONE LOSS 9 0.0006
213 QUALITY OF LIFE DECREASED 8 0.0006
214 ACUTE KIDNEY INJURY 91 0.0006
215 APPLICATION SITE PAIN 13 0.0006
216 IMPAIRED GASTRIC EMPTYING 8 0.0006
217 PRODUCT CONTAINER ISSUE 5 0.0006
218 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
219 LEFT VENTRICULAR FAILURE 2 0.0006
220 SKELETAL INJURY 6 0.0006
221 CERVICAL VERTEBRAL FRACTURE 2 0.0006
222 DERMATITIS 12 0.0006
223 RENAL INJURY 17 0.0006
224 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
225 LOGORRHOEA 2 0.0006
226 COLD SWEAT 10 0.0006
227 GENERALISED OEDEMA 7 0.0006
228 ANORECTAL DISCOMFORT 3 0.0006
229 MACULOPATHY 2 0.0006
230 FIBRIN D DIMER INCREASED 2 0.0006
231 ERYTHEMA OF EYELID 3 0.0006
232 SKIN LACERATION 6 0.0006
233 COAGULOPATHY 9 0.0005
234 SKIN HAEMORRHAGE 8 0.0005
235 HYPERACUSIS 2 0.0005
236 EYE INFECTION 6 0.0005
237 IMMUNE SYSTEM DISORDER 7 0.0005
238 EMOTIONAL DISTRESS 64 0.0005
239 PERONEAL NERVE PALSY 3 0.0005
240 PARANASAL SINUS HYPERSECRETION 2 0.0005
241 SKIN ATROPHY 3 0.0005
242 OESOPHAGEAL DISORDER 2 0.0005
243 GLAUCOMA 10 0.0005
244 MADAROSIS 6 0.0005
245 APHTHOUS ULCER 4 0.0005
246 APNOEA 4 0.0005
247 PELVIC FRACTURE 4 0.0005
248 KNEE OPERATION 5 0.0005
249 HOSPICE CARE 5 0.0005
250 SINUS HEADACHE 3 0.0005
251 DYSPNOEA EXERTIONAL 19 0.0005
252 OBSTRUCTION 2 0.0005
253 GASTROENTERITIS VIRAL 9 0.0005
254 EYE PAIN 28 0.0005
255 FUNGAL SKIN INFECTION 2 0.0005
256 ENURESIS 2 0.0005
257 NOCTURIA 6 0.0005
258 DEMYELINATION 2 0.0005
259 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
260 HAIR DISORDER 4 0.0005
261 LIMB DISCOMFORT 15 0.0005
262 INFUSION SITE EXTRAVASATION 3 0.0005
263 PULMONARY HYPERTENSION 10 0.0005
264 DRY SKIN 64 0.0005
265 ONYCHOMADESIS 2 0.0005
266 CELLULITIS 24 0.0005
267 CARDIOMYOPATHY 7 0.0005
268 MUSCLE ATROPHY 6 0.0005
269 MUSCLE FATIGUE 2 0.0005
270 FOREIGN BODY SENSATION IN EYES 3 0.0005
271 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
272 ABSCESS LIMB 2 0.0005
273 SKIN HYPERPIGMENTATION 4 0.0005
274 CARDIAC OPERATION 4 0.0005
275 HIATUS HERNIA 6 0.0005
276 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
277 SKIN SWELLING 4 0.0005
278 BIPOLAR DISORDER 5 0.0005
279 POLYP 3 0.0005
280 SPINAL OSTEOARTHRITIS 4 0.0005
281 PARONYCHIA 2 0.0005
282 PHYSICAL DISABILITY 2 0.0005
283 MUSCULOSKELETAL CHEST PAIN 7 0.0005
284 FOOT DEFORMITY 5 0.0005
285 CATHETERISATION CARDIAC 2 0.0005
286 POST-TRAUMATIC STRESS DISORDER 3 0.0004
287 FOREIGN BODY IN REPRODUCTIVE TRACT 4 0.0004
288 MALNUTRITION 5 0.0004
289 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
290 OBESITY 7 0.0004
291 BLOOD TESTOSTERONE DECREASED 3 0.0004
292 ABDOMINAL HERNIA 2 0.0004
293 DERMATITIS CONTACT 5 0.0004
294 SENSORY DISTURBANCE 7 0.0004
295 UROSEPSIS 4 0.0004
296 ARTHRITIS INFECTIVE 2 0.0004
297 BACK DISORDER 7 0.0004
298 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
299 SKIN EXFOLIATION 36 0.0004
300 PAPULE 3 0.0004
301 SKIN ULCER 11 0.0004
302 SLEEP DISORDER 30 0.0004
303 ARTERIOSCLEROSIS 4 0.0004
304 OSTEOARTHRITIS 18 0.0004
305 SEASONAL ALLERGY 6 0.0004
306 COVID-19 PNEUMONIA 5 0.0004
307 ENDOMETRIOSIS 2 0.0004
308 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
309 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
310 FAECES SOFT 3 0.0004
311 MAJOR DEPRESSION 3 0.0004
312 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
313 MOUTH HAEMORRHAGE 3 0.0004
314 PHARYNGEAL SWELLING 4 0.0004
315 CYSTITIS 13 0.0004
316 ENCEPHALOPATHY 10 0.0004
317 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
318 PANCREATIC DISORDER 2 0.0004
319 URINARY INCONTINENCE 12 0.0004
320 HYPERVOLAEMIA 2 0.0004
321 LIGAMENT SPRAIN 4 0.0004
322 FEELING DRUNK 3 0.0004
323 BLADDER DISORDER 4 0.0004
324 ABDOMINAL TENDERNESS 2 0.0004
325 HAIR COLOUR CHANGES 5 0.0004
326 TOOTH EXTRACTION 5 0.0004
327 HYPERNATRAEMIA 2 0.0004
328 DRY EYE 20 0.0004
329 FLUID INTAKE REDUCED 2 0.0004
330 BLOOD POTASSIUM DECREASED 12 0.0004
331 EMPHYSEMA 4 0.0004
332 INITIAL INSOMNIA 4 0.0004
333 CACHEXIA 2 0.0004
334 INFUSION SITE PAIN 5 0.0004
335 CONCUSSION 3 0.0004
336 FAILURE TO THRIVE 2 0.0004
337 RESTLESS LEGS SYNDROME 7 0.0004
338 BRAIN FOG 6 0.0004
339 MULTIPLE ALLERGIES 3 0.0004
340 TRANSFUSION 4 0.0004
341 APPLICATION SITE ERYTHEMA 10 0.0004
342 JOINT STIFFNESS 10 0.0004
343 TOOTH INFECTION 5 0.0004
344 FURUNCLE 3 0.0004
345 JOINT DISLOCATION 4 0.0004
346 RENAL CYST 3 0.0004
347 TRICUSPID VALVE INCOMPETENCE 3 0.0004
348 RENAL PAIN 4 0.0004
349 ATRIAL FLUTTER 3 0.0004
350 HAIR TEXTURE ABNORMAL 5 0.0004
351 UTERINE CANCER 3 0.0004
352 HEPATIC CIRRHOSIS 7 0.0004
353 PHOTOPHOBIA 7 0.0004
354 RHINITIS 3 0.0004
355 BLOOD SODIUM DECREASED 7 0.0004
356 HYPERKALAEMIA 13 0.0004
357 MUSCLE DISORDER 3 0.0004
358 CHEILITIS 2 0.0004
359 DECUBITUS ULCER 3 0.0004
360 SLEEP APNOEA SYNDROME 7 0.0004
361 CORONARY ARTERY DISEASE 11 0.0004
362 ACUTE CORONARY SYNDROME 3 0.0004
363 DENTAL CARIES 4 0.0004
364 GASTRIC ULCER HAEMORRHAGE 2 0.0004
365 INJECTION SITE INJURY 2 0.0004
366 DISCOMFORT 22 0.0004
367 TOOTH DISORDER 8 0.0004
368 POLLAKIURIA 15 0.0004
369 ATRIAL SEPTAL DEFECT 3 0.0004
370 NECK PAIN 20 0.0004
371 MASS 5 0.0004
372 ACUTE PULMONARY OEDEMA 2 0.0004
373 OCULAR DISCOMFORT 4 0.0004
374 INFUSION SITE ERYTHEMA 3 0.0004
375 HEMIPARESIS 6 0.0004
376 DEEP VEIN THROMBOSIS 23 0.0004
377 SINUS DISORDER 7 0.0004
378 MITRAL VALVE INCOMPETENCE 4 0.0004
379 HAEMATOCRIT DECREASED 7 0.0004
380 VITAMIN D DECREASED 3 0.0004
381 INTENTIONAL DOSE OMISSION 10 0.0004
382 SCAB 4 0.0004
383 PSEUDOMONAS INFECTION 3 0.0003
384 BLOOD MAGNESIUM DECREASED 3 0.0003
385 CARDIAC MURMUR 3 0.0003
386 MOUTH SWELLING 2 0.0003
387 HYSTERECTOMY 3 0.0003
388 FALL 115 0.0003
389 TASTE DISORDER 7 0.0003
390 HYPOTHYROIDISM 11 0.0003
391 ANXIETY 98 0.0003
392 ECZEMA 18 0.0003
393 POST PROCEDURAL HAEMORRHAGE 4 0.0003
394 FLUID OVERLOAD 5 0.0003
395 NAIL DISORDER 3 0.0003
396 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
397 SPINAL PAIN 4 0.0003
398 RIB FRACTURE 7 0.0003
399 TOOTH LOSS 7 0.0003
400 BACTERAEMIA 4 0.0003
401 ATAXIA 4 0.0003
402 CHOLECYSTITIS 4 0.0003
403 PRODUCTIVE COUGH 16 0.0003
404 MYOSITIS 3 0.0003
405 OROPHARYNGEAL DISCOMFORT 3 0.0003
406 HEPATITIS B 2 0.0003
407 GANGRENE 2 0.0003
408 HYPOAESTHESIA ORAL 5 0.0003
409 OSTEOMYELITIS 6 0.0003
410 LACRIMATION INCREASED 10 0.0003
411 SKIN DISORDER 11 0.0003
412 BONE DISORDER 6 0.0003
413 PRESYNCOPE 8 0.0003
414 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
415 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
416 PRODUCT DISTRIBUTION ISSUE 3 0.0003
417 ANKLE FRACTURE 5 0.0003
418 ILEUS 4 0.0003
419 APPLICATION SITE IRRITATION 4 0.0003
420 HAEMATURIA 11 0.0003
421 GAIT DISTURBANCE 61 0.0003
422 SQUAMOUS CELL CARCINOMA 3 0.0003
423 DERMATITIS ALLERGIC 4 0.0003
424 CYANOSIS 5 0.0003
425 MULTIPLE INJURIES 2 0.0003
426 OEDEMA 17 0.0003
427 POST PROCEDURAL COMPLICATION 6 0.0003
428 HYPOXIA 11 0.0003
429 CONSTIPATION 68 0.0003
430 ATELECTASIS 3 0.0003
431 CHROMATURIA 7 0.0003
432 EXPOSURE VIA SKIN CONTACT 8 0.0003
433 APPLICATION SITE VESICLES 2 0.0003
434 DRY MOUTH 25 0.0003
435 SURGERY 18 0.0003
436 COELIAC DISEASE 3 0.0003
437 NEPHROLITHIASIS 14 0.0003
438 SKIN DISCOLOURATION 14 0.0003
439 OSTEONECROSIS 10 0.0003
440 MULTIPLE FRACTURES 5 0.0003
441 DISABILITY 6 0.0003
442 PRODUCT FORMULATION ISSUE 2 0.0003
443 BLISTER 17 0.0003
444 OXYGEN SATURATION DECREASED 17 0.0003
445 APPETITE DISORDER 2 0.0003
446 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
447 EAR INFECTION 8 0.0003
448 SALIVARY HYPERSECRETION 3 0.0003
449 BRAIN INJURY 3 0.0003
450 CARDIAC FAILURE CONGESTIVE 24 0.0003
451 CHOLECYSTITIS CHRONIC 2 0.0003
452 BREAST MASS 2 0.0003
453 BACK PAIN 69 0.0003
454 SINUS CONGESTION 4 0.0003
455 DRY THROAT 3 0.0003
456 LIMB INJURY 8 0.0003
457 RASH ERYTHEMATOUS 14 0.0003
458 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
459 EAR DISCOMFORT 3 0.0003
460 ASTHMA 33 0.0003
461 PARANOIA 5 0.0003
462 BALANCE DISORDER 25 0.0003
463 ENCEPHALITIS 2 0.0003
464 NEURALGIA 7 0.0003
465 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
466 APHONIA 4 0.0003
467 PRODUCT ODOUR ABNORMAL 3 0.0003
468 PSORIASIS 37 0.0003
469 SINUS TACHYCARDIA 4 0.0003
470 DIVERTICULUM 2 0.0003
471 RETCHING 6 0.0003
472 JOINT INJURY 6 0.0003
473 AGEUSIA 7 0.0003
474 CONTUSION 27 0.0003
475 FEAR OF INJECTION 2 0.0003
476 ARTHRITIS 22 0.0003
477 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
478 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
479 OESOPHAGITIS 3 0.0003
480 NEUROPATHY PERIPHERAL 26 0.0003
481 STAPHYLOCOCCAL INFECTION 9 0.0003
482 ORAL DISORDER 2 0.0003
483 ILLNESS 28 0.0003
484 DYSURIA 10 0.0003
485 CEREBRAL DISORDER 2 0.0003
486 BRONCHITIS 20 0.0003
487 CATARACT 16 0.0003
488 ORAL PAIN 6 0.0003
489 THROAT IRRITATION 12 0.0003
490 HYDRONEPHROSIS 2 0.0003
491 RASH 116 0.0003
492 GASTRITIS 7 0.0003
493 DYSARTHRIA 10 0.0003
494 PAIN IN EXTREMITY 78 0.0003
495 BLOOD URINE PRESENT 5 0.0003
496 RHINORRHOEA 17 0.0003
497 MICTURITION URGENCY 3 0.0003
498 CHOLECYSTECTOMY 3 0.0003
499 INTERNAL HAEMORRHAGE 3 0.0003
500 VISION BLURRED 36 0.0003
501 BOWEL MOVEMENT IRREGULARITY 2 0.0003
502 LIPASE INCREASED 2 0.0003
503 NEOPLASM 3 0.0003
504 EYE IRRITATION 15 0.0003
505 LOWER LIMB FRACTURE 5 0.0003
506 DEVICE RELATED INFECTION 4 0.0003
507 THYROID DISORDER 4 0.0003
508 DEPRESSION 59 0.0003
509 OROPHARYNGEAL PAIN 24 0.0003
510 RASH PRURITIC 14 0.0003
511 ELECTROLYTE IMBALANCE 3 0.0003
512 RASH MACULAR 9 0.0003
513 EPISTAXIS 19 0.0003
514 PRODUCT USE COMPLAINT 4 0.0003
515 PERIPHERAL SWELLING 39 0.0003
516 PRURITUS 97 0.0003
517 PROCEDURAL PAIN 7 0.0003
518 RESPIRATORY TRACT CONGESTION 4 0.0003
519 ACCIDENT 3 0.0003
520 MACULAR DEGENERATION 3 0.0003
521 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
522 HYPERTENSION 53 0.0002
523 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
524 MOVEMENT DISORDER 8 0.0002
525 PRODUCT DOSE OMISSION ISSUE 73 0.0002
526 LOCALISED INFECTION 6 0.0002
527 TREMOR 41 0.0002
528 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
529 BLOOD CREATININE INCREASED 16 0.0002
530 PAIN 150 0.0002
531 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
532 TENDON RUPTURE 3 0.0002
533 VENTRICULAR TACHYCARDIA 4 0.0002
534 WEIGHT DECREASED 67 0.0002
535 HAEMODIALYSIS 2 0.0002
536 ASCITES 7 0.0002
537 RENAL IMPAIRMENT 20 0.0002
538 TYPE 2 DIABETES MELLITUS 8 0.0002
539 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
540 HALLUCINATION, VISUAL 5 0.0002
541 HYPOPHAGIA 6 0.0002
542 FACIAL PARALYSIS 2 0.0002
543 COVID-19 41 0.0002
544 ROTATOR CUFF SYNDROME 3 0.0002
545 MUSCLE STRAIN 2 0.0002
546 NODULE 3 0.0002
547 ORTHOSTATIC HYPOTENSION 4 0.0002
548 DEVICE USE ISSUE 4 0.0002
549 URINARY TRACT INFECTION 39 0.0002
550 ORAL CANDIDIASIS 3 0.0002
551 HYPOAESTHESIA 34 0.0002
552 ABNORMAL BEHAVIOUR 9 0.0002
553 FEMUR FRACTURE 7 0.0002
554 ATRIAL FIBRILLATION 22 0.0002
555 MEMORY IMPAIRMENT 31 0.0002
556 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
557 SEPSIS 25 0.0002
558 FACIAL PAIN 2 0.0002
559 MUSCLE SPASMS 41 0.0002
560 PULMONARY OEDEMA 10 0.0002
561 PAIN OF SKIN 6 0.0002
562 HEAVY MENSTRUAL BLEEDING 2 0.0002
563 PRODUCT TASTE ABNORMAL 3 0.0002
564 COMPLICATION OF DEVICE REMOVAL 4 0.0002
565 TACHYPNOEA 3 0.0002
566 LUPUS-LIKE SYNDROME 2 0.0002
567 PELVIC PAIN 4 0.0002
568 OPTIC NEURITIS 2 0.0002
569 DIARRHOEA 142 0.0002
570 LEUKOPENIA 11 0.0002
571 DECREASED APPETITE 51 0.0002
572 CORONARY ARTERY OCCLUSION 3 0.0002
573 SKIN LESION 6 0.0002
574 PERIPHERAL COLDNESS 3 0.0002
575 RESPIRATORY ARREST 6 0.0002
576 INCREASED TENDENCY TO BRUISE 2 0.0002
577 ABNORMAL DREAMS 6 0.0002
578 NERVE COMPRESSION 2 0.0002
579 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
580 CHEST PAIN 40 0.0002
581 CONJUNCTIVITIS 4 0.0002
582 CHEST DISCOMFORT 22 0.0002
583 HEPATIC STEATOSIS 4 0.0002
584 RENAL DISORDER 10 0.0002
585 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
586 BACTERIAL INFECTION 4 0.0002
587 DEFORMITY 2 0.0002
588 BLOOD TEST ABNORMAL 3 0.0002
589 FLANK PAIN 2 0.0002
590 MYALGIA 36 0.0002
591 OCULAR HYPERAEMIA 10 0.0002
592 BLOOD PRESSURE DECREASED 14 0.0002
593 EXPIRED PRODUCT ADMINISTERED 7 0.0002
594 GASTRIC ULCER 4 0.0002
595 CONFUSIONAL STATE 34 0.0002
596 MUSCULOSKELETAL DISORDER 4 0.0002
597 ANAEMIA 40 0.0002
598 GAIT INABILITY 7 0.0002
599 ANGINA PECTORIS 6 0.0002
600 ARTHRALGIA 87 0.0002
601 EYE PRURITUS 7 0.0002
602 AFFECT LABILITY 2 0.0002
603 SEPTIC SHOCK 9 0.0002
604 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
605 DIZZINESS POSTURAL 2 0.0002
606 FIBROMYALGIA 5 0.0002
607 HAEMORRHOIDS 4 0.0002
608 DYSPNOEA 116 0.0002
609 ORAL HERPES 4 0.0002
610 SINUSITIS 21 0.0002
611 SOMNOLENCE 41 0.0002
612 COUGH 57 0.0002
613 BLOOD PRESSURE INCREASED 31 0.0002
614 VISUAL IMPAIRMENT 25 0.0002
615 PULMONARY MASS 3 0.0002
616 INABILITY TO AFFORD MEDICATION 2 0.0002
617 COLON CANCER 3 0.0002
618 IMMUNODEFICIENCY 3 0.0002
619 BURNING SENSATION 14 0.0002
620 SPINAL FRACTURE 4 0.0002
621 HOT FLUSH 15 0.0002
622 FULL BLOOD COUNT DECREASED 4 0.0002
623 PLEURAL EFFUSION 12 0.0002
624 EYELID PTOSIS 2 0.0002
625 FLUID RETENTION 10 0.0002
626 FATIGUE 153 0.0002
627 INSURANCE ISSUE 3 0.0002
628 HYPOKALAEMIA 9 0.0002
629 TENDONITIS 3 0.0002
630 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
631 INFECTION 28 0.0002
632 POOR VENOUS ACCESS 2 0.0002
633 DELUSION 3 0.0002
634 ACUTE MYELOID LEUKAEMIA 3 0.0002
635 SWELLING 18 0.0002
636 BASAL CELL CARCINOMA 3 0.0002
637 HERPES ZOSTER 11 0.0002
638 ROAD TRAFFIC ACCIDENT 8 0.0002
639 INJECTION SITE DISCOMFORT 2 0.0002
640 KNEE ARTHROPLASTY 4 0.0002
641 HEAD INJURY 6 0.0002
642 MIGRAINE 18 0.0002
643 ABSCESS 3 0.0002
644 BREAST PAIN 2 0.0002
645 IMPAIRED WORK ABILITY 4 0.0002
646 DIZZINESS 93 0.0002
647 NIGHT SWEATS 6 0.0002
648 POOR QUALITY SLEEP 4 0.0002
649 HALLUCINATION 14 0.0002
650 WHEEZING 11 0.0002
651 MUSCLE TIGHTNESS 3 0.0002
652 UNEVALUABLE EVENT 14 0.0002
653 MUSCULAR WEAKNESS 21 0.0002
654 BLOOD POTASSIUM INCREASED 3 0.0002
655 PRODUCT DOSE OMISSION 12 0.0002
656 LUNG DISORDER 9 0.0002
657 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
658 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
659 CHOLELITHIASIS 6 0.0002
660 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
661 PNEUMONIA 59 0.0002
662 HOSPITALISATION 28 0.0002
663 GASTROINTESTINAL PAIN 2 0.0002
664 DRUG LEVEL INCREASED 3 0.0002
665 VIRAL INFECTION 6 0.0002
666 FUNGAL INFECTION 6 0.0002
667 STEVENS-JOHNSON SYNDROME 4 0.0002
668 SYNCOPE 18 0.0002
669 NERVE INJURY 2 0.0002
670 BLOOD UREA INCREASED 3 0.0002
671 WOUND 5 0.0002
672 ADVERSE DRUG REACTION 16 0.0002
673 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
674 INSOMNIA 47 0.0002
675 FLATULENCE 10 0.0002
676 APPLICATION SITE PRURITUS 4 0.0002
677 MYOCARDIAL ISCHAEMIA 2 0.0002
678 INJECTION SITE BRUISING 14 0.0002
679 RED BLOOD CELL COUNT DECREASED 5 0.0002
680 SKIN IRRITATION 8 0.0002
681 HYPERSOMNIA 5 0.0002
682 GASTRIC HAEMORRHAGE 2 0.0002
683 MULTI-ORGAN FAILURE 3 0.0002
684 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
685 METASTASES TO LUNG 2 0.0002
686 DEHYDRATION 23 0.0002
687 OEDEMA PERIPHERAL 21 0.0002
688 HEADACHE 108 0.0002
689 LOCAL SWELLING 3 0.0002
690 DYSSTASIA 5 0.0002
691 DYSPHONIA 10 0.0002
692 ASTHENIA 64 0.0002
693 LYMPHADENOPATHY 6 0.0002
694 PSYCHOTIC DISORDER 5 0.0002
695 DYSPHAGIA 16 0.0002
696 ISCHAEMIC STROKE 3 0.0002
697 THERAPY INTERRUPTED 12 0.0002
698 MYOCLONUS 2 0.0002
699 VOMITING 78 0.0002
700 HEPATITIS C 2 0.0002
701 THERAPEUTIC RESPONSE DECREASED 10 0.0002
702 BURSITIS 2 0.0002
703 HYPOTENSION 33 0.0002
704 TREATMENT NONCOMPLIANCE 9 0.0002
705 RESTLESSNESS 6 0.0002
706 HAEMATOCHEZIA 9 0.0002
707 NAUSEA 129 0.0002
708 DYSPEPSIA 16 0.0002
709 CARDIOMEGALY 2 0.0002
710 THROMBOSIS 13 0.0002
711 PHARYNGITIS 2 0.0002
712 PANCYTOPENIA 9 0.0002
713 THINKING ABNORMAL 3 0.0002
714 ABDOMINAL DISCOMFORT 27 0.0002
715 ERYTHEMA 33 0.0002
716 SWOLLEN TONGUE 5 0.0002
717 FEELING ABNORMAL 38 0.0002
718 FRACTURE 3 0.0002
719 PROTEINURIA 3 0.0002
720 INJECTION SITE IRRITATION 2 0.0002
721 MOOD SWINGS 5 0.0002
722 THERAPY CESSATION 8 0.0002
723 HAEMOGLOBIN DECREASED 16 0.0002
724 HERNIA 3 0.0002
725 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
726 EAR PAIN 3 0.0002
727 BONE PAIN 9 0.0002
728 CEREBROVASCULAR ACCIDENT 26 0.0002
729 NASAL CONGESTION 9 0.0002
730 ALOPECIA 30 0.0002
731 IMPAIRED HEALING 5 0.0002
732 BEDRIDDEN 2 0.0002
733 EYE DISORDER 5 0.0002
734 DISORIENTATION 6 0.0002
735 HEART RATE INCREASED 15 0.0002
736 CONDITION AGGRAVATED 46 0.0002
737 BLOOD PRESSURE ABNORMAL 3 0.0002
738 DYSMENORRHOEA 2 0.0002
739 RESPIRATORY FAILURE 11 0.0002
740 LIP SWELLING 5 0.0001
741 COGNITIVE DISORDER 7 0.0001
742 MENSTRUATION IRREGULAR 4 0.0001
743 MALIGNANT MELANOMA 2 0.0001
744 JOINT RANGE OF MOTION DECREASED 2 0.0001
745 FEAR 4 0.0001
746 STOMATITIS 9 0.0001
747 DEVICE BREAKAGE 6 0.0001
748 SEIZURE 17 0.0001
749 BODY TEMPERATURE INCREASED 3 0.0001
750 FEELING HOT 9 0.0001
751 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
752 APPLICATION SITE RASH 2 0.0001
753 RESPIRATORY DISTRESS 4 0.0001
754 NIGHTMARE 5 0.0001
755 HYPOGLYCAEMIA 7 0.0001
756 ARTHROPATHY 8 0.0001
757 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
758 HUNGER 2 0.0001
759 INJECTION SITE SWELLING 11 0.0001
760 INFLUENZA 16 0.0001
761 INJECTION SITE PAIN 44 0.0001
762 BLOOD GLUCOSE INCREASED 27 0.0001
763 CARPAL TUNNEL SYNDROME 2 0.0001
764 DEVICE OCCLUSION 2 0.0001
765 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
766 DIALYSIS 2 0.0001
767 ABDOMINAL PAIN UPPER 29 0.0001
768 LIVER FUNCTION TEST INCREASED 3 0.0001
769 HYPERHIDROSIS 18 0.0001
770 SKIN CANCER 3 0.0001
771 LETHARGY 8 0.0001
772 AMNESIA 9 0.0001
773 NEEDLE ISSUE 4 0.0001
774 APATHY 2 0.0001
775 GASTROENTERITIS 2 0.0001
776 LABORATORY TEST ABNORMAL 4 0.0001
777 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
778 THROMBOCYTOPENIA 15 0.0001
779 RASH PAPULAR 3 0.0001
780 SNEEZING 3 0.0001
781 RESPIRATORY DISORDER 4 0.0001
782 INTESTINAL OBSTRUCTION 5 0.0001
783 APHASIA 4 0.0001
784 RHEUMATOID ARTHRITIS 15 0.0001
785 DEVICE FAILURE 2 0.0001
786 VERTIGO 8 0.0001
787 DIABETES MELLITUS 10 0.0001
788 TINNITUS 6 0.0001
789 HIP ARTHROPLASTY 2 0.0001
790 MUSCLE TWITCHING 3 0.0001
791 PHARYNGEAL OEDEMA 2 0.0001
792 LUNG INFECTION 2 0.0001
793 PRODUCT PRESCRIBING ERROR 3 0.0001
794 HALLUCINATION, AUDITORY 2 0.0001
795 INTENTIONAL PRODUCT MISUSE 11 0.0001
796 MUSCULOSKELETAL STIFFNESS 11 0.0001
797 MOBILITY DECREASED 9 0.0001
798 BLOOD PRESSURE FLUCTUATION 3 0.0001
799 BLOOD GLUCOSE DECREASED 6 0.0001
800 ABDOMINAL PAIN 29 0.0001
801 ABDOMINAL DISTENSION 13 0.0001
802 HIP FRACTURE 4 0.0001
803 HYPONATRAEMIA 7 0.0001
804 MENTAL IMPAIRMENT 3 0.0001
805 PSORIATIC ARTHROPATHY 5 0.0001
806 DYSKINESIA 5 0.0001
807 MANIA 2 0.0001
808 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
809 PNEUMONIA ASPIRATION 3 0.0001
810 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
811 URINARY RETENTION 4 0.0001
812 CARDIO-RESPIRATORY ARREST 5 0.0001
813 ABDOMINAL PAIN LOWER 3 0.0001
814 MALAISE 52 0.0001
815 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
816 CANDIDA INFECTION 2 0.0001
817 ANGER 4 0.0001
818 CARDIAC DISORDER 11 0.0001
819 WEIGHT INCREASED 26 0.0001
820 DIPLOPIA 3 0.0001
821 VAGINAL HAEMORRHAGE 5 0.0001
822 NERVOUSNESS 6 0.0001
823 DEAFNESS 3 0.0001
824 MUSCULOSKELETAL PAIN 6 0.0001
825 PARAESTHESIA 18 0.0001
826 AMENORRHOEA 2 0.0001
827 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
828 HEART RATE DECREASED 4 0.0001
829 INJURY 8 0.0001
830 METASTASES TO LIVER 2 0.0001
831 DEPRESSED MOOD 6 0.0001
832 HYPERSENSITIVITY 21 0.0001
833 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
834 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
835 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
836 PLATELET COUNT DECREASED 12 0.0001
837 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
838 CARDIAC FAILURE 9 0.0001
839 GALLBLADDER DISORDER 2 0.0001
840 THERAPY NON-RESPONDER 5 0.0001
841 FREQUENT BOWEL MOVEMENTS 3 0.0001
842 BLOOD BILIRUBIN INCREASED 3 0.0001
843 PALPITATIONS 13 0.0001
844 LEUKOCYTOSIS 2 0.0001
845 CRYING 4 0.0001
846 DISEASE PROGRESSION 13 0.0001
847 ACCIDENTAL OVERDOSE 4 0.0001
848 SUICIDAL IDEATION 10 0.0001
849 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
850 TREATMENT FAILURE 9 0.0001
851 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
852 BLOOD GLUCOSE ABNORMAL 2 0.0001
853 DIVERTICULITIS 3 0.0001
854 INJECTION SITE MASS 4 0.0001
855 DEATH 93 0.0001
856 FEELING COLD 3 0.0001
857 DRUG INEFFECTIVE 142 0.0001
858 EYE SWELLING 4 0.0001
859 SWELLING FACE 7 0.0001
860 BLOOD CHOLESTEROL INCREASED 5 0.0001
861 MIDDLE INSOMNIA 2 0.0001
862 PRODUCT USE ISSUE 20 0.0001
863 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
864 PULMONARY EMBOLISM 10 0.0001
865 FEELING JITTERY 2 0.0001
866 INCREASED APPETITE 2 0.0001
867 PRESCRIBED OVERDOSE 2 0.0001
868 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
869 PLASMA CELL MYELOMA 4 0.0001
870 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
871 KIDNEY INFECTION 2 0.0001
872 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
873 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
874 DEVICE ISSUE 9 0.0001
875 PRESCRIBED UNDERDOSE 2 0.0001
876 DEVICE MALFUNCTION 7 0.0001
877 HEPATIC FAILURE 3 0.0001
878 JOINT SWELLING 12 0.0001
879 OFF LABEL USE 87 0.0001
880 FEEDING DISORDER 2 0.0001
881 BLINDNESS 4 0.0001
882 NEUTROPHIL COUNT DECREASED 4 0.0001
883 INJECTION SITE RASH 3 0.0001
884 LUNG NEOPLASM MALIGNANT 4 0.0001
885 NERVOUS SYSTEM DISORDER 3 0.0001
886 PYREXIA 33 0.0001
887 PANCREATITIS 5 0.0001
888 BRADYCARDIA 5 0.0001
889 METABOLIC ACIDOSIS 3 0.0001
890 LOSS OF CONSCIOUSNESS 12 0.0001
891 RECTAL HAEMORRHAGE 4 0.0001
892 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
893 FAECES DISCOLOURED 2 0.0001
894 DEVICE DISLOCATION 4 0.0001
895 MENTAL DISORDER 4 0.0001
896 PRODUCT DISPENSING ERROR 2 0.0001
897 MELAENA 2 0.0001
898 ANGIOEDEMA 4 0.0001
899 HEPATOTOXICITY 2 0.0001
900 INJECTION SITE PRURITUS 6 0.0001
901 GLOSSODYNIA 2 0.0001
902 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
903 GASTROINTESTINAL DISORDER 8 0.0001
904 PANCREATITIS ACUTE 2 0.0001
905 HEART RATE IRREGULAR 2 0.0001
906 HEPATIC ENZYME INCREASED 6 0.0001
907 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
908 PRODUCT AVAILABILITY ISSUE 2 0.0001
909 INJECTION SITE HAEMORRHAGE 7 0.0001
910 GASTRIC DISORDER 3 0.0001
911 INJECTION SITE REACTION 6 0.0001
912 ADVERSE EVENT 8 0.0001
913 NASOPHARYNGITIS 16 0.0001
914 CHILLS 10 0.0001
915 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
916 CEREBRAL HAEMORRHAGE 3 0.0001
917 SKIN BURNING SENSATION 6 0.0001
918 MULTIPLE SCLEROSIS 4 0.0001
919 IRRITABILITY 5 0.0001
920 DRUG INTOLERANCE 8 0.0001
921 PANIC ATTACK 3 0.0001
922 ILL-DEFINED DISORDER 5 0.0001
923 AGITATION 6 0.0001
924 ABASIA 2 0.0001
925 DYSGEUSIA 6 0.0001
926 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
927 AGGRESSION 4 0.0001
928 COLITIS 3 0.0001
929 HAEMATEMESIS 2 0.0001
930 FLUSHING 8 0.0001
931 URTICARIA 13 0.0001
932 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
933 MUCOSAL INFLAMMATION 2 0.0001
934 SPEECH DISORDER 4 0.0001
935 DEVICE DIFFICULT TO USE 5 0.0001
936 BREAST CANCER 7 0.0001
937 DISTURBANCE IN ATTENTION 4 0.0001
938 PRODUCT QUALITY ISSUE 10 0.0001
939 NEUTROPENIA 10 0.0001
940 PALLOR 2 0.0001
941 PNEUMONITIS 2 0.0001
942 INFLUENZA LIKE ILLNESS 6 0.0001
943 CARDIAC ARREST 6 0.0001
944 MENTAL STATUS CHANGES 2 0.0001
945 MEDICATION ERROR 4 0.0001
946 RHABDOMYOLYSIS 3 0.0001
947 HAEMOPTYSIS 2 0.0001
948 DEMENTIA 2 0.0001
949 WITHDRAWAL SYNDROME 3 0.0001
950 RENAL FAILURE ACUTE 3 0.0001
951 PAIN IN JAW 2 0.0001
952 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
953 INCORRECT DOSE ADMINISTERED 16 0.0001
954 HYPOACUSIS 3 0.0001
955 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
956 PANCREATIC CARCINOMA 2 0.0001
957 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
958 PRODUCT STORAGE ERROR 6 0.0001
959 ACUTE MYOCARDIAL INFARCTION 2 0.0001
960 EMOTIONAL DISORDER 2 0.0001
961 MYOCARDIAL INFARCTION 11 0.0001
962 RENAL CANCER 3 0.0001
963 INTERSTITIAL LUNG DISEASE 3 0.0001
964 DRUG DOSE OMISSION 10 0.0001
965 INFUSION RELATED REACTION 4 0.0001
966 FEBRILE NEUTROPENIA 4 0.0001
967 NEOPLASM MALIGNANT 4 0.0001
968 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
969 INFLAMMATION 3 0.0001
970 DELIRIUM 2 0.0001
971 DRUG WITHDRAWAL SYNDROME 5 0.0001
972 TACHYCARDIA 5 0.0001
973 DRUG EFFECT DECREASED 3 0.0001
974 UNDERDOSE 4 0.0001
975 ANAPHYLACTIC REACTION 3 0.0001
976 BLADDER CANCER 3 0.0001
977 DRUG INTERACTION 8 0.0001
978 SUICIDE ATTEMPT 3 0.0000
979 INJECTION SITE ERYTHEMA 6 0.0000
980 LIVER DISORDER 2 0.0000
981 COLITIS ULCERATIVE 2 0.0000
982 ARRHYTHMIA 2 0.0000
983 COMA 2 0.0000
984 OVERDOSE 9 0.0000
985 HAEMORRHAGE 4 0.0000
986 DRUG DEPENDENCE 5 0.0000
987 NO ADVERSE EVENT 5 0.0000
988 ACNE 2 0.0000
989 DRUG ABUSE 2 0.0000
990 TOXICITY TO VARIOUS AGENTS 4 0.0000